Endoscopic Ultrasound: Contrast Enhancement

Gastrointestinal Endoscopy Clinics of North America

Volumn 22, Issue 2, 2012, Pages 349-358

  Kitano, Masayuki ^a   Sakamoto, Hiroki ^a   Kudo, Masatoshi ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Contrast enhancement; Contrast enhanced harmonic EUS; Definity; Endoscopic ultrasonography; Microbubbles; Sonazoid; SonoVue; Ultrasound contrast agents

Indexed keywords

CARBON DIOXIDE; PERFLUBUTANE; PERFLUTREN; SHU 508; SONOVUE;

ASPIRATION BIOPSY; CANCER DIAGNOSIS; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DOPPLER ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; GASTROINTESTINAL STROMAL TUMOR; HUMAN; MULTIDETECTOR COMPUTED TOMOGRAPHY; OUTCOME ASSESSMENT; PANCREAS CARCINOMA; PRIORITY JOURNAL; REVIEW; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME;

BIOPSY, FINE-NEEDLE; BLOOD VESSELS; CARCINOMA; CONTRAST MEDIA; ENDOSONOGRAPHY; HUMANS; IMAGE ENHANCEMENT; PANCREAS; PANCREATIC NEOPLASMS; ULTRASONOGRAPHY, DOPPLER, COLOR; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84861468733     PISSN: 10525157     EISSN: 15581950     Source Type: Journal    
DOI: 10.1016/j.giec.2012.04.013     Document Type: Review

References (41)

1. 2 microbubbles. Radiology 1986, 161:701-705.
2. 2 micorbubbles. Radiology 1992, 182:155-160.
3. Kato T., Tsukamoto Y., Naitoh Y., et al. Ultrasonographic and endoscopic ultrasonographic angiography in pancreatic mass lesions. Acta Radiol 1995, 36:381-387.
4. Sanchez M.V., Varadarajulu S., Napoleon B. EUS contrast agents: what is available, how do they work, and are they effective?. Gastrointest Endosc 2009, 69:571-577.
5. Reddy N.K., Ioncicâ A.M., Sâftoiu A., et al. Contrast-enhanced endoscopic ultrasonography. World J Gastroenterol 2011, 17:42-48.
6. Whittingham T.A. Contrast-specific imaging techniques; technical perspective. Contrast media in ultrasonography. Basic principles and clinical applications 2005, 43-84. Springer, Berlin. E. Quaia (Ed.).
7. Kudo M. Various contrast-enhanced imaging modes after administration of Levovist. Contrast harmonic imaging in the diagnosis and treatment of hepatic tumors 2003, 22-30. Springer, Tokyo. M. Kudo (Ed.).
8. Kitano M., Kudo M., Maekawa K., et al. Dynamic imaging of pancreatic diseases by contrast enhanced coded phase inversion harmonic ultrasonography. Gut 2004, 53:854-859.
9. Kitano M., Kudo M., Sakamoto H., et al. Endoscopic ultrasonography and contrast-enhanced endoscopic ultrasonography. Pancreatology 2011, 11(Suppl 2):28-33.
10. Hirooka Y., Goto H., Ito A., et al. Contrast-enhanced endoscopic ultrasonography in pancreatic diseases: a preliminary study. Am J Gastroenterol 1998, 93:632-635.
11. Hirooka Y., Naitoh Y., Goto H., et al. Usefulness of contrast-enhanced endoscopic ultrasonography with intravenous injection of sonicated serum albumin. Gastrointest Endosc 1997, 46:166-169.
12. Wiersema M.J., Chak A., Kopecky K.K., et al. Duplex Doppler endosonography in the diagnosis of splenic vein, portal vein, and portosystemic shunt thrombosis. Gastrointest Endosc 1995, 42:19-26.
13. Bhutani M.S., Hoffman B.J., van Velse A., et al. Contrast-enhanced endoscopic ultrasonography with galactose microparticles: SHU508A (Levovist). Endoscopy 1997, 29:635-639.
14. Hocke M., Schulze E., Gottschalk P., et al. Contrast-enhanced endoscopic ultrasound in discrimination between focal pancreatitis and pancreatic cancer. World J Gastroenterol 2006, 12:246-250.
15. Sakamoto H., Kitano M., Suetomi Y., et al. Utility of contrast-enhanced endoscopic ultrasonography for diagnosis of small pancreatic carcinomas. Ultrasound Med Biol 2008, 34:525-532.
16. Sâftoiu A., Iordache S.A., Gheonea D.I., et al. Combined contrast-enhanced power Doppler and real-time sonoelastography performed during EUS, used in the differential diagnosis of focal pancreatic masses (with videos). Gastrointest Endosc 2010, 72:739-747.
17. Becker D., Strobel D., Bernatik T., et al. Echo-enhanced color- and power-Doppler EUS for the discrimination between focal pancreatitis and pancreatic carcinoma. Gastrointest Endosc 2001, 53:784-789.
18. Dietrich C.F., Ignee A., Braden B., et al. Improved differentiation of pancreatic tumors using contrast-enhanced endoscopic ultrasound. Clin Gastroenterol Hepatol 2008, 6:590-597.
19. Ishikawa T., Itoh A., Kawashima H., et al. Usefulness of EUS combined with contrast-enhancement in the differential diagnosis of malignant versus benign and preoperative localization of pancreatic endocrine tumors. Gastrointest Endosc 2010, 71:951-959.
20. Kanamori A., Hirooka Y., Itoh A., et al. Usefulness of contrast-enhanced endoscopic ultrasonography in the differentiation between malignant and benign lymphadenopathy. Am J Gastroenterol 2006, 101:45-51.
21. DeWitt J., Devereaux B., Chriswell M., et al. Comparison of endoscopic ultrasonography and multidetector computed tomography for detecting and staging pancreatic cancer. Ann Intern Med 2004, 141:753-763.
22. Sâftoiu A., Vilmann P. Role of endoscopic ultrasound in the diagnosis and staging of pancreatic cancer. J Clin Ultraound 2009, 37:1-17.
23. Rösch T., Lightdale C.J., Botet J.F., et al. Localization of pancreatic endocrine tumors by endoscopic ultrasonography. N Engl J Med 1992, 326:1721-1726.
24. Khashab M.A., Yong E., Lennon A.M., et al. EUS is still superior to multidetector computed tomography for detection of pancreatic neuroendocrine tumors. Gastrointest Endosc 2011, 73:691-696.
25. Hocke M., Menges M., Topalidis T., et al. Contrast-enhanced endoscopic ultrasound in discrimination between benign and malignant mediastinal and abdominal lymph nodes. J Cancer Res Clin Oncol 2008, 134:473-480.
26. Kitano M., Kudo M., Sakamoto H., et al. Preliminary study of contrast-enhanced harmonic endosonography with second-generation contrast agents. J Med Ultrasonics 2008, 35:11-18.
27. Kitano M., Sakamoto H., Matsui U., et al. A novel perfusion imaging technique of the pancreas: contrast-enhanced harmonic EUS (with video). Gastrointest Endosc 2008, 67:141-150.
28. Dietrich C.F., Ignee A., Frey H. Contrast-enhanced endoscopic ultrasound with low mechanical index: a new technique. Z Gastroenterol 2005, 43:1219-1223.
29. Napoleon B., Alvarez-Sanchez M.V., Gincoul R., et al. Contrast-enhanced harmonic endoscopic ultrasound in solid lesions of the pancreas: results of a pilot study. Endoscopy 2010, 42:564-570.
30. Fusaroli P., Spada A., Mancino M.G., et al. Contrast harmonic echo-endoscopic ultrasound improves accuracy in diagnosis of solid pancreatic masses. Clin Gastroenterol Hepatol 2010, 8:629-634.
31. Kitano M., Kudo M., Yamao K., et al. Characterization of small solid tumors in the pancreas: contrast: the value of contrast-enhanced harmonic endoscopic ultrasonography. Am J Gastroenterol 2012, 107:303-310.
32. Bhutani M.S., Gress F.G., Giovannini M., et al. The no endosonographic detection of tumor (NEST) study: a case series of pancreatic cancers missed on endoscopic ultrasonography. Endoscopy 2004, 36:385-389.
33. Imazu H., Uchiyama Y., Matsunaga K., et al. Contrast-enhanced harmonic EUS with novel ultrasonographic contrast (Sonazoid) in the preoperative T-staging for pancreaticobiliary malignancies. Scand J Gastroenterol 2010, 45:732-738.
34. Xia Y., Kitano M., Kudo M., et al. Characterization of intra-abdominal lesions of undetermined origin by contrast-enhanced harmonic EUS (with video). Gastrointest Endosc 2010, 72:637-642.
35. Sakamoto H., Kitano M., Matsui S., et al. Estimation of malignant potential of GI stromal tumors by contrast-enhanced harmonic EUS (with videos). Gastrointest Endosc 2011, 73:227-237.
36. DeWitt J. EUS in pancreatic neoplasms. Endosonography 2006, 177-203. Saunders Elsevier, Philadelphia. R.H. Hawes, P. Fockens (Eds.).
37. Romagnuolo J., Hoffman B., Vela S., et al. Accuracy of contrast-enhanced harmonic EUS with a second-generation perflutren lipid microsphere contrast agent (with video). Gastrointest Endosc 2011, 73:52-63.
38. Willmann J.K., Lutz A.M., Paulmurugan R., et al. Dual-targeted contrast agent for US assessment of tumor angiogenesis in vivo. Radiology 2008, 248:936-944.
39. Palmowski M., Huppert J., Ladewig G., et al. Molecular profiling of angiogenesis with targeted ultrasound imaging: early assessment of antiangiogenic therapy effects. Mol Cancer Ther 2008, 7:101-109.
40. Giday S.A., Magno P., Gabrielson K.L., et al. The utility of contrast enhanced endoscopic ultrasound in monitoring ethanol-induced pancreatic tissue ablation: a pilot study in a porcine model. Endoscopy 2007, 39:525-529.
41. Hermot S., Klibanov A.L. Microbubbles in ultrasound-triggered drug and gene delivery. Adv Drug Deliv Rev 2008, 60:1153-1166.